0001790340-24-000002.txt : 20240102 0001790340-24-000002.hdr.sgml : 20240102 20240102162606 ACCESSION NUMBER: 0001790340-24-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Feinberg Peter CENTRAL INDEX KEY: 0001870076 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40675 FILM NUMBER: 24502790 MAIL ADDRESS: STREET 1: C/O IMMUNEERING CORPORATION STREET 2: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immuneering Corp CENTRAL INDEX KEY: 0001790340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-500-8080 MAIL ADDRESS: STREET 1: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wk-form4_1704230750.xml FORM 4 X0508 4 2024-01-01 0 0001790340 Immuneering Corp IMRX 0001870076 Feinberg Peter 245 MAIN STREET SECOND FLOOR CAMBRIDGE MA 02142 1 0 0 0 0 Stock Option 7.35 2024-01-01 4 A 0 6879 0 A 2034-01-01 Class A Common Stock 6879 6879 D Pursuant to the Immuneering Corporation Non-Employee Director Compensation Program (the "Compensation Program"), the reporting person elected to receive this stock option in lieu of receiving the cash Base Retainer (as defined in the Compensation Program). The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in the Compensation Program) following the grant date, such that the fourth and final installment will vest and become exercisable on the first anniversary of the grant date, subject in each case to such continuous service. By: /s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg 2024-01-02